Results 131 to 140 of about 2,225,996 (214)

Comparative Cost Evaluation of Managed Entry Agreement Techniques Using Real-World Data from High-Cost Anticancer Drugs in Thailand. [PDF]

J Mark Access Health Policy
Owat P, Sooksriwong C, Ratanabunjerdkul H, Phodha T.   +3 more
europepmc   +1 more source

Molecular Dynamics Simulation of Passive Diffusion across a Human Breast Cancer Cell Membrane Model. Comparison between Cisplatin and Its Pt(IV) Derivatives. [PDF]

J Chem Inf Model
Belletto D, Scoditti S, Borocci S, Sanna N, Zazza C, Sicilia E.   +5 more
europepmc   +1 more source

Quantitative Evaluation of Model-Informed Drug Development Implementation in China's Approved Innovative Drugs: From Policy to Practice (2018-2024). [PDF]

CPT Pharmacometrics Syst Pharmacol
Li J, Wang Z, Wei C, He R, Yao Q.
europepmc   +1 more source

Accelerating cancer therapy review: a cross-sectional analysis of expedited approval in China, 2005-2021. [PDF]

BMC Cancer
Tian Y, Liu X, Liu X, Liu X, Hu S, Liu X, Yang C, Fang Y.   +7 more
europepmc   +1 more source

Association Between Single-Nucleotide Polymorphism and Trastuzumab Deruxtecan-Induced Interstitial Lung Disease in Breast Cancer Using the Japonica Array NEO. [PDF]

Cancers (Basel)
Fujiwara S, Saito N, Yasukawa M, Narita A, Sakurai-Yageta M, Sato S, Yamashita T, Hoshino D.   +7 more
europepmc   +1 more source

Price transparency & out-of-pocket payments for medications: Implications of associated delivery fees in the United States. [PDF]

Health Policy Open
Kaye DR, Lee HJ, George DJ, Scales CD, Bundorf MK.   +4 more
europepmc   +1 more source

Intra-subtype heterogeneity shapes treatment response in <i>KMT2A</i>-rearranged ALL across all age groups. [PDF]

Hemasphere
Hartmann AM, Bastian L, Barz MJ, Haas J, Amelunxen E, Ehm P, Lenk L, Kotrova M, Beder T, Steffen FD, Rauwolf K, Wolgast N, Bendig S, Bozzetti C, Alten J, Mondal M, Rademacher A, Heymann J, Walter W, Haferlach C, Ströh AS, Bergmann AK, Burmeister T, Gökbuget N, Bornhauser B, Bourquin JP, Brüggemann M, Schrappe M, Cario G, Baldus CD.   +29 more
europepmc   +1 more source

Real time, on-site drug checking in low-threshold housing communities. [PDF]

Harm Reduct J
Summers C, Silcox J, Zaragoza S, Rapisarda S, Edelmann A, Chatterjee A, Green TC.   +6 more
europepmc   +1 more source

Brief report: Meth, tranq, gas station heroin & other drugs complicating addiction treatment. [PDF]

Am J Addict
Winstanley EL, Liebschutz JM, Murray-Krezan C, Switzer GE, Nash S, Kawasaki S.   +5 more
europepmc   +1 more source

Prescription Drugs Subject to a Risk Evaluation and Mitigation Strategy: Patient Perspectives on Risk Communication and the Value of Educational Materials. [PDF]

Drug Saf
Chimonas S, Cosenza C, Kesselheim AS, Toyserkani GA, Oswell KH, LaCivita C, Dal Pan GJ, Sarpatwari A.   +7 more
europepmc   +1 more source